ArticleBritish journal of clinical pharmacology2022

A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV-2 mediated inflammation to organ damage.

Yogendra Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.